Rachel Raab

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

William Irvin, Christine M. Walko, Karen E. Weck et al. · Journal of Clinical Oncology · 2011 · 179 citations

Medicine, Pharmacokinetics, Pharmacology +17

Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer

Li Jun Di, Jung S. Byun, Madeline Wong et al. · Nature Communications · 2013 · 177 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

<i>In vivo</i> assessment of the metabolic activity of CYP2D6 diplotypes and alleles

Daniel L. Hertz, Anna C. Snavely, Howard L. McLeod et al. · British Journal of Clinical Pharmacology · 2015 · 57 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity

Daniel L. Hertz, Allison M. Deal, Joseph G. Ibrahim et al. · The Oncologist · 2016 · 54 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Patient Navigation and the Quality of Breast Cancer Care: An Analysis of the Breast Cancer Care Quality Indicators

Joseph J. Weber, Debra C. Mascarenhas, Lisa Bellin et al. · Annals of Surgical Oncology · 2012 · 41 citations

Medicine, Oncology, Oncology Nursing +16